Search research articles
Contact Us
Filters
Showing results (81-90 of 202) with videos related to
Page
of 21
Sort By:
Cancer Research
|
December 21, 2006
Matrix metalloproteinase polymorphisms and bladder cancer risk
A Karim Kader, Lina Shao, Colin P Dinney, et al.
European Urology
|
May 9, 2012
Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center
Siobhan P Lynch, Yu Shen, Ashish Kamat, et al.
World Journal of Urology
|
November 12, 2018
The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside
Jonathan J Duplisea, Sharada Mokkapati, Devin Plote, et al.
The Journal of Urology
|
April 19, 2021
Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy
Kelly K Bree, Patrick J Hensley, Mary E Westerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2007
Projecting individualized probabilities of developing bladder cancer in white individuals
Xifeng Wu, Jie Lin, H Barton Grossman, et al.
BJU International
|
September 14, 2007
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging
Boris A Hadaschik, Peter C Black, Jason C Sea, et al.
European Urology Oncology
|
December 18, 2021
Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin
Niyati Lobo, Patrick J Hensley, Kelly K Bree, et al.
American Journal of Clinical Pathology
|
April 4, 2017
Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases
Melanie D Fox, Li Xiao, Miao Zhang, et al.
European Urology
|
October 11, 2018
Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease
Roger Li, William B Tabayoyong, Charles C Guo, et al.
Plos One
|
August 11, 2012
Detection of bladder cancer using proteomic profiling of urine sediments
Tadeusz Majewski, Philippe E Spiess, Jolanta Bondaruk, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 202) with videos related to
Sort By:
Page
of 21
Cancer Research
|
December 21, 2006
Matrix metalloproteinase polymorphisms and bladder cancer risk
A Karim Kader, Lina Shao, Colin P Dinney, et al.
European Urology
|
May 9, 2012
Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center
Siobhan P Lynch, Yu Shen, Ashish Kamat, et al.
World Journal of Urology
|
November 12, 2018
The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside
Jonathan J Duplisea, Sharada Mokkapati, Devin Plote, et al.
The Journal of Urology
|
April 19, 2021
Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy
Kelly K Bree, Patrick J Hensley, Mary E Westerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2007
Projecting individualized probabilities of developing bladder cancer in white individuals
Xifeng Wu, Jie Lin, H Barton Grossman, et al.
BJU International
|
September 14, 2007
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging
Boris A Hadaschik, Peter C Black, Jason C Sea, et al.
European Urology Oncology
|
December 18, 2021
Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin
Niyati Lobo, Patrick J Hensley, Kelly K Bree, et al.
American Journal of Clinical Pathology
|
April 4, 2017
Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases
Melanie D Fox, Li Xiao, Miao Zhang, et al.
European Urology
|
October 11, 2018
Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease
Roger Li, William B Tabayoyong, Charles C Guo, et al.
Plos One
|
August 11, 2012
Detection of bladder cancer using proteomic profiling of urine sediments
Tadeusz Majewski, Philippe E Spiess, Jolanta Bondaruk, et al.
Page
of 21